Armin Szegedi

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. pmc Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis
    Pilar Cazorla
    Merck, Rahway, NJ, USA
    Neuropsychiatr Dis Treat 9:409-13. 2013
  2. pmc Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
    Pilar Cazorla
    Formerly, Merck Rahway, NJ, USA
    Neuropsychiatr Dis Treat 8:247-57. 2012
  3. doi Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program
    Armin Szegedi
    Merck, Rahway, NJ, USA
    J Affect Disord 150:745-52. 2013
  4. doi Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics
    Armin Szegedi
    Merck, Rahway, NJ 07065, USA
    J Clin Psychiatry 73:1533-40. 2012
  5. doi Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension
    Armin Szegedi
    Merck, Rahway, NJ 07065, USA
    J Clin Psychopharmacol 32:46-55. 2012
  6. pmc Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials
    Armin Szegedi
    Merck Research Laboratories, Rahway, NJ, USA
    BMC Psychiatry 11:101. 2011

Collaborators

Detail Information

Publications6

  1. pmc Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis
    Pilar Cazorla
    Merck, Rahway, NJ, USA
    Neuropsychiatr Dis Treat 9:409-13. 2013
    ....
  2. pmc Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
    Pilar Cazorla
    Formerly, Merck Rahway, NJ, USA
    Neuropsychiatr Dis Treat 8:247-57. 2012
    ..Here, we describe the safety and tolerability of switching existing antipsychotic treatments to asenapine or olanzapine monotherapy using various switching regimens...
  3. doi Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program
    Armin Szegedi
    Merck, Rahway, NJ, USA
    J Affect Disord 150:745-52. 2013
    ....
  4. doi Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics
    Armin Szegedi
    Merck, Rahway, NJ 07065, USA
    J Clin Psychiatry 73:1533-40. 2012
    ..Asenapine is an approved treatment for schizophrenia in the United States...
  5. doi Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension
    Armin Szegedi
    Merck, Rahway, NJ 07065, USA
    J Clin Psychopharmacol 32:46-55. 2012
    ..Adjunctive asenapine to lithium or valproate was more effective than mood stabilizer monotherapy in the core study and was well tolerated for up to 52 weeks...
  6. pmc Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials
    Armin Szegedi
    Merck Research Laboratories, Rahway, NJ, USA
    BMC Psychiatry 11:101. 2011
    ..We report the results of exploratory pooled post hoc analyses from these trials evaluating asenapine's effects on depressive symptoms in patients from these trials with significant baseline depressive symptoms...